RxDoctor Payments DataLook up a doctor →

Jeffrey McAlister, DPM

Foot & Ankle Surgery · Scottsdale, AZNPI 1568698074

Payments from drug & device makers

$652,566in general payments, 2019–2025

Across 1,045 payments — averaging $624.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$175K
  • Medline Industries LP$174K
  • Linvatec Corporation$64K
  • Stryker$32K
  • Smith+Nephew$30K
  • Globus Medical$30K
  • plus $149K from 40 others
$5,425in research payments, 2019–2025

Across 2 payments — averaging $2712.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Avitus Orthopaedics, Inc.$5K
  • Biotissue Holdings Inc.$525

What the payments were for

  • Royalty or licence$77,37913%
  • Consulting fees$344,38360%
  • Speaking & faculty fees$29,8505%
  • Travel & lodging$63,51911%
  • Food & beverage$28,2355%
  • Education$7,7391%
  • Gifts$900%
  • Entertainment$1,0510%
  • Other$26,0825%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$652,566 in reported general payments places this provider in the 95th percentile of 291 foot & ankle surgery providers in Arizona.

See all foot & ankle surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$204,474
Medicare patients
328
Services billed
1,872

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin167$946
Ondansetron Hcl117$686
Oxycodone Hcl95$486
Cephalexin111$395
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$204
Terbinafine Hcl11$185
Ciprofloxacin Hcl15$71
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$71
Tramadol Hcl14$31

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →